Talking Euretina

Episode 12: Journal Club - Subretinal Hemorrhages and the TIGER study

This Journal Club is all about subretinal hemorrhaging as we take a look at 2 relevant papers and hear the latest developments of the Euretina-sponsored TIGER Study. It is chaired by Professors Grazia Pertile (Sacro Cuore Hospital Negrar, Verona) and Siegfried Priglinger (LMU Munich).  They're joined by Professor Timothy Jackson (King’s College, London), Dr Emilia Maggio (Sacro Cuore Hospital Negrar, Verona) and Dr Saskia van Romunde (The Rotterdam Eye Hospital)

Episode 11: Imaging and AMD - Pathology, Biomarkers and Big Data

In this episode, Professor Sandrine Zweifel (Switzerland) and Professor Adnan Tufail (UK) chair a discussion on how imaging has affected our understanding of AMD. They discuss the impact of new biomarkers and also explore the effect of big data on this field now and into the future. Contributing faculty are Professor Christine Curcio (USA), Professor K Bailey Freund (USA) and Professor Srinivas Sadda (USA).

Episode 10: Diagnosis and Management of Uveitic Macular Edema

In this episode, Carlos Pavesio (UK) and Sofia Androudi (Greece) share their experience and insights in the diagnosis and treatment of macular edema. Chaired by Bahram Bodaghi (France).

Episode 9: The Importance of Data Storytelling with Brent Dykes

In this episode, we hear from Brent Dykes  about the importance of storytelling with data and how to implement it when communicating research. Brent is author of Effective Data Storytelling, founder of Analytics Hero and a regular contributor to Forbes.

Episode 8: The Euretina Mentorship Programme

In this episode, we explore the benefits of the Euretina Mentorship Programme. Guests are programme mentor and Euretina Board member, Dr Patricia Udaondo and Dara Conlon, Euretina Executive Vice President.

Episode 7: Exploring the Faricimab Trials

In January, The Lancet journal published studies showing that across 4 trials, faricimab improved and maintained vision in two leading causes of vision loss and reduced time between treatments. In this episode, we examine the results and implications of the research in an expert discussion chaired by Prof Anat Loewenstein (Tel Aviv Medical Centre) and Prof Reinier Schlingemann (Amsterdam University and Jules Gonin). They are joined by Ramin Tadayoni (Paris University), Professor Sandrine Zweifel (University Hospital Zurich) and Professor Usha Chakravarthy (Queen's University Belfast)

Episode 6: Exciting developments in the treatment of metastatic melanoma

In this episode, Professors Heinrich Heimann (Liverpool University Hospital) and Jens Kiilgaard (Copenhagen University Hospital) chair a conversation about metastatic disease in uveal melanoma and a newly approved treatment, Tebentafusp. They’re joined by Dr Joseph Sacco (Liverpool University Hospital) and Dr Mette Bagger (Copenhagen University Hospital)

Episode 5: Inherited Retinal Diseases

In this episode on inherited retinal diseases, we explore issues related to genetic testing: when it's needed, how access differs globally and when to refer patients to super specialist IRD centres. The discussion is chaired by Professor Bart LeRoy (Belgium) and Professor Isabelle Audo (Sorbonne France) with Dr Rola Ba-Abbad (Saudi Arabia) and Prof Graeme Black (UK).

Episode 4: Journal Club - Retinal Imaging & AI

In this Journal Club episode, Tunde Peto from Queen’s University, Belfast and Sebastian Wolf from Inselspital in Bern chair a discussion on key papers in retinal imaging and AI. First, Pearse Keane of University College London presents work on the use of AI in the detection of papilledema (1). Tariq Aslam from Manchester University then explores the issues arising from a 2021 paper comparing different algorithms in diabetic retinopathy screening (2).

 

(1): https://www.nejm.org/doi/full/10.1056/NEJMoa1917130

 

(2): https://pubmed.ncbi.nlm.nih.gov/33402366

Episode 3: Hot Topics in Diabetic Retinopathy

In this episode, Professors Edoardo Midena (Padua University Hospital) and Reinier Schlingemann (Amsterdam UMC) chair a discussion around some of the hot topics in the subspecialty field of diabetic retinopathy. Joined by Professors Jennifer Sun (Joslin Diabetes Center, Harvard Medical School) and Jakob Grauslund (University of Southern Denmark), they discuss:

 

- The treatment of non-proliferative diabetic retinopathy with anti-VEGF intravitreal injections

 

- Faricimab, a new drug for the treatment of diabetic macular edema. The rationale and preliminary data

 

- Artificial intelligence in the screening of diabetic retinopathy: pearls and pitfalls